A case of balloon rupture during insertion of an intragastric balloon for treatment of morbid obesity

Öz

The therapeutic options for treatment of morbid obesity are diet, exercise, behavioral modifications, medical treatment and bariatric surgery. An alternative approach to surgery is the endoscopic placement in the stomach of balloons which are filled with liquid, providing a sensation of fullness that decreases food consumption. The rate of complications associated with the placement of intragastric balloons is low. A significant late complication is deflation and/or displacement of the balloon. The migration of the balloon can cause acute intestinal obstruction. In this report, we present a case of balloon rupture during insertion of an intragastric balloon for treatment of morbid obesity. Intragastric balloon placement and related complications are also reviewed.

Anahtar Kelimeler

• Intragastric balloon, rupture

Morbid obezite tedavisinde intragastrik balon uygulaması sırasında meydana gelen balon rüptürü vakası

Öz

Morbid obezitenin tedavi seçenekleri diyet, eksersiz, davranış modifikasyonları, medikal tedavi ve bariatrik cerrahidir. Cerrahiye alternatif bir yaklaşım, sıvı ile doldurulmuş bir balonun mideye endoskopik yerleştirilmesi, böylece doluluk hissi oluşturarak gıda tüketiminin azaltılmasıdır. İntragastrik balon yerleştirilmesi ile ilişkili komplikasyonlar düşüktür. Önemli bir geç komplikasyonu balonun sönmesi ve/veya yer değiştirmesidir. Balonun migrasyonu akut intestinal obstrüksiyona sebep olabilir. Bu yazıda morbid obezite tedavisi için intragastrik balon yerleştirilmesi sırasında meydana gelen bir balon rüptürü vakası sunulmuştur. Ayrıca intragastrik balon yerleştirilmesi ve ilişkili komplikasyonlar gözden geçirilmiştir.

Anahtar Kelimeler

• İntragastrik balon, rüptür

Kaynakça

1. Griffen WO Jr, Bivins BA, Bell RM. The decline and fall of the jeju- noileal bypass. Surg Gynecol Obstet. 1983; 157: 301-8.
2. Knol JA, Strodel WE, Eckhauser FE. Critical appraisal of horizon- tal gastroplasty. Am J Surg. 1987; 153: 256-61.
3. MacLean LD, Rhode BM, Sampalis J, et al. Results of the surgical treatment of obesity. Am J Surg. 1993; 165: 155-60.
4. Owen ER, Abraham R, Kark AE. Gastroplasty for morbid obesity: technique, complications and results in 60 cases. Br J Surg. 1989; 76: 131-5.
5. Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment- resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc. 2005; 6: 19-27.
6. Evans JD, Scott MH. Intragastric balloon in the treatment of pati- ents with morbid obesity. Br J Surg. 2001; 88: 1245-8.
7. Ulicny KS Jr, Goldberg SJ, Harper WJ. et al. Surgical complicati- ons of the Garren-Edwards Gastric Bubble. Surg Gynecol Obstet. 1988; 166: 535-40.
8. Mathus-Vliegen EM, Tytgat GN, Veldhuyzen-Offermans EA. Intra- gastric balloon in the treatment of super-morbid obesity. Double- blind, sham-controlled, crossover evaluation of 500-milliliter ballo- on. Gastroenterology. 1990; 99: 362-9.

9. Rubio PA. Esophageal rupture secondary to passage of a gastric bubble for weight control. Arch Surg. 1988; 123: 394-5.
10. Spyropoulos C, Katsakoulis E, Mead N et al. Intragastric balloon for high-risk super-obese patients: a prospective analysis of effi- cacy. Surg Obes Relat Dis. 2007; 3: 78-83.
11. Genco A, Bruni T, Doldi SB et al. BioEnterics Intragastric Balloon: The Italian Experience with 2515 Patients. Obes Surg. 2005; 15: 1161-4.
12. Al-Momen A, El-Mogy I. Intragastric balloon for obesity: a retros- pective evaluation of tolerance and efficacy. Obes Surg. 2005; 15: 101-5.
13. Nijhof HW, Steenvoorde P, Tollenaar RA. Perforation of the esop- hagus caused by the insertion of an intragastric balloon for the tre- atment of obesity. Obes Surg. 2006; 16: 667-70.
14. Genco A, Cipriano M, Bacci V. et al. BioEnterics Intragastric Bal- loon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes (Lond). 2006; 30: 129-33.